National Net Income From Continuing Ops vs Other Operating Expenses Analysis

NRC Stock

USD 19.48 0.06 0.31%

National Research financial indicator trend analysis is infinitely more than just investigating National Research Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National Research Corp is a good investment. Please check the relationship between National Research Net Income From Continuing Ops and its Other Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Net Income From Continuing Ops vs Other Operating Expenses

Net Income From Continuing Ops vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National Research Corp Net Income From Continuing Ops account and Other Operating Expenses. At this time, the significance of the direction appears to have strong relationship.

The correlation between National Research's Net Income From Continuing Ops and Other Operating Expenses is 0.69. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of National Research Corp, assuming nothing else is changed. The correlation between historical values of National Research's Net Income From Continuing Ops and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of National Research Corp are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Income From Continuing Ops i.e., National Research's Net Income From Continuing Ops and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Net Income From Continuing Ops

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of National Research Corp. It is also known as National Research overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from National Research's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National Research Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

At present, National Research's Enterprise Value Over EBITDA is projected to decrease significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 36.71, whereas Tax Provision is forecasted to decline to about 7.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	95.6M	94.5M	86.7M	91.0M
Total Revenue	148.0M	151.6M	148.6M	156.0M

Gross Profit Total Revenue

National Research fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Non Current Liabilities Total	Other Current Assets	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Short Term Debt	Other Liab	Long Term Debt
Total Assets		0.78	0.3	0.71	0.35	0.54	0.42	0.77	0.26	-0.34	0.02	0.23	0.71	0.89	0.65	0.71	0.87	0.3	0.79	0.18	0.81	0.21	-0.46	-0.08	0.47	0.12
Total Stockholder Equity	0.78		-0.11	0.42	-0.2	-0.02	-0.09	0.31	0.06	-0.6	0.58	0.22	0.78	0.55	0.21	0.78	0.57	-0.25	0.49	0.02	0.82	-0.31	-0.08	-0.21	0.07	-0.42
Other Assets	0.3	-0.11		0.39	0.92	0.72	0.68	0.31	0.43	0.43	-0.8	-0.33	0.13	0.28	0.59	0.13	0.41	0.81	0.7	0.6	0.28	0.82	-0.82	0.29	0.86	0.82
Common Stock Shares Outstanding	0.71	0.42	0.39		0.5	0.52	0.65	0.63	0.16	-0.29	-0.24	0.21	0.6	0.58	0.42	0.6	0.55	0.38	0.6	0.1	0.65	0.36	-0.69	-0.34	0.6	0.3
Other Stockholder Equity	0.35	-0.2	0.92	0.5		0.84	0.79	0.49	0.35	0.42	-0.91	-0.24	0.07	0.39	0.75	0.07	0.48	0.9	0.61	0.4	0.21	0.88	-0.81	0.24	0.83	0.89
Total Liab	0.54	-0.02	0.72	0.52	0.84		0.7	0.73	0.63	0.4	-0.7	0.04	0.06	0.67	0.7	0.06	0.61	0.92	0.67	0.56	0.25	0.88	-0.75	0.27	0.77	0.84
Other Current Liab	0.42	-0.09	0.68	0.65	0.79	0.7		0.63	0.21	0.08	-0.7	-0.18	0.17	0.44	0.53	0.17	0.52	0.64	0.43	0.25	0.26	0.64	-0.72	0.0	0.66	0.65
Total Current Liabilities	0.77	0.31	0.31	0.63	0.49	0.73	0.63		0.26	-0.13	-0.28	0.44	0.4	0.78	0.58	0.4	0.72	0.44	0.6	0.16	0.5	0.42	-0.52	0.13	0.55	0.3
Property Plant And Equipment Net	0.26	0.06	0.43	0.16	0.35	0.63	0.21	0.26		0.63	-0.26	-0.16	-0.26	0.49	0.12	-0.26	0.35	0.61	0.48	0.87	-0.05	0.67	-0.54	0.4	0.45	0.56
Net Debt	-0.34	-0.6	0.43	-0.29	0.42	0.4	0.08	-0.13	0.63		-0.59	-0.45	-0.77	0.0	0.09	-0.77	-0.04	0.59	0.08	0.57	-0.62	0.68	-0.31	0.62	0.26	0.65
Retained Earnings	0.02	0.58	-0.8	-0.24	-0.91	-0.7	-0.7	-0.28	-0.26	-0.59		0.3	0.26	-0.11	-0.55	0.26	-0.17	-0.85	-0.3	-0.31	0.17	-0.85	0.63	-0.29	-0.65	-0.91
Accounts Payable	0.23	0.22	-0.33	0.21	-0.24	0.04	-0.18	0.44	-0.16	-0.45	0.3		0.4	0.09	-0.13	0.4	-0.07	-0.23	0.06	-0.22	0.33	-0.25	0.07	-0.26	0.05	-0.29
Cash	0.71	0.78	0.13	0.6	0.07	0.06	0.17	0.4	-0.26	-0.77	0.26	0.4		0.32	0.31	1.0	0.39	-0.14	0.52	-0.12	0.97	-0.21	-0.22	-0.38	0.3	-0.25
Non Current Assets Total	0.89	0.55	0.28	0.58	0.39	0.67	0.44	0.78	0.49	0.0	-0.11	0.09	0.32		0.66	0.32	0.9	0.47	0.71	0.29	0.46	0.39	-0.43	0.11	0.4	0.29
Non Currrent Assets Other	0.65	0.21	0.59	0.42	0.75	0.7	0.53	0.58	0.12	0.09	-0.55	-0.13	0.31	0.66		0.31	0.75	0.67	0.62	0.08	0.42	0.52	-0.45	0.12	0.53	0.55
Cash And Short Term Investments	0.71	0.78	0.13	0.6	0.07	0.06	0.17	0.4	-0.26	-0.77	0.26	0.4	1.0	0.32	0.31		0.39	-0.14	0.52	-0.12	0.97	-0.21	-0.22	-0.38	0.3	-0.25
Net Receivables	0.87	0.57	0.41	0.55	0.48	0.61	0.52	0.72	0.35	-0.04	-0.17	-0.07	0.39	0.9	0.75	0.39		0.42	0.71	0.2	0.55	0.35	-0.53	0.14	0.5	0.26
Non Current Liabilities Total	0.3	-0.25	0.81	0.38	0.9	0.92	0.64	0.44	0.61	0.59	-0.85	-0.23	-0.14	0.47	0.67	-0.14	0.42		0.57	0.58	0.04	0.94	-0.69	0.25	0.71	0.98
Other Current Assets	0.79	0.49	0.7	0.6	0.61	0.67	0.43	0.6	0.48	0.08	-0.3	0.06	0.52	0.71	0.62	0.52	0.71	0.57		0.56	0.67	0.55	-0.69	0.21	0.74	0.45
Property Plant And Equipment Gross	0.18	0.02	0.6	0.1	0.4	0.56	0.25	0.16	0.87	0.57	-0.31	-0.22	-0.12	0.29	0.08	-0.12	0.2	0.58	0.56		0.06	0.67	-0.54	0.43	0.51	0.58
Total Current Assets	0.81	0.82	0.28	0.65	0.21	0.25	0.26	0.5	-0.05	-0.62	0.17	0.33	0.97	0.46	0.42	0.97	0.55	0.04	0.67	0.06		-0.03	-0.38	-0.26	0.45	-0.1
Short Long Term Debt Total	0.21	-0.31	0.82	0.36	0.88	0.88	0.64	0.42	0.67	0.68	-0.85	-0.25	-0.21	0.39	0.52	-0.21	0.35	0.94	0.55	0.67	-0.03		-0.77	0.46	0.73	0.93
Intangible Assets	-0.46	-0.08	-0.82	-0.69	-0.81	-0.75	-0.72	-0.52	-0.54	-0.31	0.63	0.07	-0.22	-0.43	-0.45	-0.22	-0.53	-0.69	-0.69	-0.54	-0.38	-0.77		-0.16	-0.94	-0.67
Short Term Debt	-0.08	-0.21	0.29	-0.34	0.24	0.27	0.0	0.13	0.4	0.62	-0.29	-0.26	-0.38	0.11	0.12	-0.38	0.14	0.25	0.21	0.43	-0.26	0.46	-0.16		0.13	0.23
Other Liab	0.47	0.07	0.86	0.6	0.83	0.77	0.66	0.55	0.45	0.26	-0.65	0.05	0.3	0.4	0.53	0.3	0.5	0.71	0.74	0.51	0.45	0.73	-0.94	0.13		0.69
Long Term Debt	0.12	-0.42	0.82	0.3	0.89	0.84	0.65	0.3	0.56	0.65	-0.91	-0.29	-0.25	0.29	0.55	-0.25	0.26	0.98	0.45	0.58	-0.1	0.93	-0.67	0.23	0.69

Click cells to compare fundamentals

National Research Account Relationship Matchups

National Research fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	110.7M	133.4M	157.5M	130.5M	122.4M	80.7M
Total Stockholder Equity	32.9M	64.3M	85.3M	72.0M	49.0M	45.4M
Other Assets	5.4M	8.9M	9.8M	5.7M	6.6M	6.9M
Common Stock Shares Outstanding	25.7M	25.7M	25.6M	25.1M	24.7M	14.8M
Liabilities And Stockholders Equity	110.7M	133.4M	157.5M	130.5M	122.4M	80.7M
Other Stockholder Equity	128.4M	128.1M	123.8M	97.2M	79.5M	83.4M
Total Liab	77.8M	69.1M	72.2M	58.4M	73.5M	77.2M
Other Current Liab	12.2M	10.9M	17.0M	12.6M	12.6M	7.2M
Total Current Liabilities	38.2M	31.7M	40.4M	33.4M	36.2M	23.7M
Property Plant And Equipment Net	13.5M	11.7M	12.4M	17.2M	30.3M	31.8M
Net Debt	20.7M	(4.1M)	(27.8M)	(2.8M)	32.3M	33.9M
Retained Earnings	(93.4M)	(61.4M)	(36.1M)	(25.2M)	(30.5M)	(29.0M)
Accounts Payable	4.9M	1.1M	1.9M	1.2M	1.3M	1.2M
Cash	13.5M	34.7M	54.4M	25.0M	6.7M	6.3M
Non Current Assets Total	81.5M	79.3M	83.8M	86.7M	98.1M	58.5M
Non Currrent Assets Other	10.1M	10.3M	9.8M	7.9M	4.7M	4.5M
Cash And Short Term Investments	13.5M	34.7M	54.4M	25.0M	6.7M	6.3M
Net Receivables	11.7M	14.2M	13.8M	14.6M	12.5M	9.1M
Non Current Liabilities Total	39.6M	37.4M	31.8M	25.0M	37.3M	39.1M
Other Current Assets	3.9M	5.2M	5.5M	4.1M	5.2M	3.8M
Property Plant And Equipment Gross	15.2M	13.0M	46.6M	17.2M	65.9M	69.2M
Total Current Assets	29.2M	54.1M	73.7M	43.7M	24.4M	30.4M
Accumulated Other Comprehensive Income	(1.6M)	(2.9M)	(2.2M)	(2.4M)	(2.4M)	0.0
Short Long Term Debt Total	34.7M	30.6M	26.5M	22.2M	39.0M	40.9M
Intangible Assets	1.7M	1.4M	1.8M	1.6M	1.5M	1.4M
Short Term Debt	4.4M	5.0M	5.2M	5.3M	7.2M	7.6M
Other Liab	8.1M	10.9M	9.5M	6.9M	8.0M	8.4M
Long Term Debt	29.8M	26.5M	22.3M	17.7M	29.5M	30.9M
Treasury Stock	(33.7M)	(43.7M)	(50.1M)	(78.3M)	(70.4M)	(66.9M)
Property Plant Equipment	13.5M	11.7M	12.4M	17.2M	19.8M	14.1M
Current Deferred Revenue	16.6M	15.6M	17.2M	15.2M	14.8M	14.4M
Good Will	57.8M	57.9M	57.3M	61.6M	55.5M	52.7M
Retained Earnings Total Equity	(93.4M)	(61.4M)	(36.1M)	(25.2M)	(22.7M)	(21.5M)
Deferred Long Term Liab	4.2M	4.6M	3.8M	5.3M	4.7M	3.4M
Net Tangible Assets	32.9M	64.3M	23.7M	8.8M	10.1M	9.6M
Capital Surpluse	162.2M	171.8M	173.9M	175.5M	201.8M	110.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National Research's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.25)

Dividend Share

0.48

Earnings Share

1.12

Revenue Per Share

6.013

Quarterly Revenue Growth

(0.06)

The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Net Income From Continuing Ops vs Other Operating Expenses Analysis

Net Income From Continuing Ops vs Other Operating Expenses

Net Income From Continuing Ops vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Other Operating Expenses

National Research fundamental ratios Correlations

National Research Account Relationship Matchups

High Positive Relationship

High Negative Relationship

National Research fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Long Term Debt	+ 0.98	Non Current Liabilities Total
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Short Long Term Debt Total	+ 0.94	Non Current Liabilities Total
Long Term Debt	+ 0.93	Short Long Term Debt Total

Other Liab	- 0.94	Intangible Assets
Long Term Debt	- 0.91	Retained Earnings
Retained Earnings	- 0.91	Other Stockholder Equity
Short Long Term Debt Total	- 0.85	Retained Earnings
Non Current Liabilities Total	- 0.85	Retained Earnings
Intangible Assets	- 0.82	Other Assets